![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Home | GSK US
The homepage of the GSK USA website
Company | GSK US
Getting ahead of disease is one of the greatest, most inspiring challenges there is on the planet. By pursuing this purpose together, we have the scale and expertise to positively impact the health of 2.5 billion people by the end of the decade. In doing so, we will deliver stronger and more sustainable growth as a company where people can thrive.
Careers | GSK US
Ahead Together. At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Contact us - GSK
Get in touch USA Pennsylvania Address: GSK 2929 Walnut Street Ste. 1700 Philadelphia, PA 19104. North Carolina Address: GSK 410 Blackwell St. Durham, NC 27701
Vaccines | GSK US
We are leading the way in developing a broad portfolio and innovative pipeline of vaccines to make an impact for society. We deliver over two million vaccine doses per day to people living in over 160 countries.
Products | GSK US
Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more product information on our GSKPro website.. In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center.
Search jobs | GSK US
Explore our career opportunities all over the world
Press releases | GSK US
January 10 2025 GSK’s Shingrix new prefilled syringe presentation accepted for review by US FDA . If approved, the new presentation will offer a convenient administration option to healthcare professionals.
At a glance | GSK US
Over the last two years we have played a key role to develop treatments and vaccines against COVID. Through a partnership with Vir Biotechnology we have developed, and contracted, with the US Government for approximately $1 billion for our monoclonal antibody, Sotrovimab, which demonstrated it can reduce hospitalization and risk of death by 79% in adults with mild-to …
Purpose, strategy and culture | GSK US
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the of decade, a s a successful, growing company where people can thrive.